Portfolio case studies

What is your vision? What is the problem you are trying to solve?

Minimal access surgery (MAS) has well documented benefits for patients, including reduced pain, discomfort, scarring and risk of infection, along with faster recovery times, when compared with open surgery. These advantages mean that MAS is widely recognised as the best treatment option for soft tissue surgeries.

However, MAS is extremely difficult to perform, which means that 50% of cases globally that could be treated this way are still being performed as open surgery.

The support of robotic systems should help to address this problem by making MAS less mentally and physically challenging for surgeons. However, robotic systems have historically not been easily accessible to all hospitals. In fact, only 3% of all surgeries globally are being performed with a robot. In Europe it is closer to just 1% of surgeries.

CIC has vast experience in the life sciences sector and knows the industry in which we operate very well. They have shared our vision from the beginning and supported us through many stages of development. Their support has been critically important and I look forward to working together in the future.

SUPRATIM BOSE CEO

At CMR Surgical, our goal is to transform surgery – for good. As the fastest growing surgical robotics company, we are rapidly disrupting the surgical robotics market, bringing the benefits of minimal access surgery to more patients around the world every day with Versius, our next generation robot.

What is unique about your product/technology?

Versius is the only small, modular and portable surgical robotic system, which means that it can integrate seamlessly into virtually any operating room. Due to the modular design, Versius can easily be moved between hospital departments to maximise utilisation so that more patients can benefit from robotic-assisted MAS.